These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8691436)
21. Rationally designed inhibitors of inosine monophosphate dehydrogenase. Zhang HZ; Rao K; Carr SF; Papp E; Straub K; Wu JC; Fried J J Med Chem; 1997 Jan; 40(1):4-8. PubMed ID: 9016322 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of thiazole-4-carboxamide-adenine difluoromethylenediphosphonates substituted with fluorine at C-2' of the adenosine. Zatorski A; Lipka P; Mollova N; Schram KH; Goldstein BM; Watanabe KA; Pankiewicz KW Carbohydr Res; 1993 Oct; 249(1):95-108. PubMed ID: 8252557 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases. Moreau A; Rao PN; Knaus EE Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817 [TBL] [Abstract][Full Text] [Related]
24. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors. Franchetti P; Cappellacci L; Perlini P; Jayaram HN; Butler A; Schneider BP; Collart FR; Huberman E; Grifantini M J Med Chem; 1998 May; 41(10):1702-7. PubMed ID: 9572896 [TBL] [Abstract][Full Text] [Related]
25. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships. Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773 [TBL] [Abstract][Full Text] [Related]
26. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419). Watterson SH; Chen P; Zhao Y; Gu HH; Dhar TG; Xiao Z; Ballentine SK; Shen Z; Fleener CA; Rouleau KA; Obermeier M; Yang Z; McIntyre KW; Shuster DJ; Witmer M; Dambach D; Chao S; Mathur A; Chen BC; Barrish JC; Robl JA; Townsend R; Iwanowicz EJ J Med Chem; 2007 Jul; 50(15):3730-42. PubMed ID: 17585753 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiviral evaluation of certain disubstituted benzimidazole ribonucleosides. Zou R; Ayres KR; Drach JC; Townsend LB J Med Chem; 1996 Aug; 39(18):3477-82. PubMed ID: 8784445 [TBL] [Abstract][Full Text] [Related]
28. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor. Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase. Gebeyehu G; Marquez VE; Kelley JA; Cooney DA; Jayaram HN; Johns DG J Med Chem; 1983 Jun; 26(6):922-5. PubMed ID: 6133956 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. Suzuki T; Ando T; Tsuchiya K; Fukazawa N; Saito A; Mariko Y; Yamashita T; Nakanishi O J Med Chem; 1999 Jul; 42(15):3001-3. PubMed ID: 10425110 [TBL] [Abstract][Full Text] [Related]
31. Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships. Buckley GM; Davies N; Dyke HJ; Gilbert PJ; Hannah DR; Haughan AF; Hunt CA; Pitt WR; Profit RH; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC Bioorg Med Chem Lett; 2005 Feb; 15(3):751-4. PubMed ID: 15664851 [TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of indazole adenine dinucleotides on proliferation of normal and malignant cells. Tono-Oka S; Tone Y; Azuma I Int J Vitam Nutr Res; 1986; 56(1):119-24. PubMed ID: 2872178 [TBL] [Abstract][Full Text] [Related]
36. Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: quest for specific inhibition of inosine monophosphate dehydrogenase. Pankiewicz KW Pharmacol Ther; 1997; 76(1-3):89-100. PubMed ID: 9535171 [TBL] [Abstract][Full Text] [Related]
37. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model. Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955 [TBL] [Abstract][Full Text] [Related]
38. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791 [TBL] [Abstract][Full Text] [Related]
39. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment. Chen L; Wilson D; Jayaram HN; Pankiewicz KW J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969 [TBL] [Abstract][Full Text] [Related]
40. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity. Pankiewicz KW; Zatorski A; Watanabe KA Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]